Am. J. Respir. Crit. Care Med., Volume 164, Number 3, August 2001, 443-446

Exercise Inhibits Epithelial Sodium Channels in Patients with Cystic Fibrosis

ALEXANDRA HEBESTREIT, ULRICH KERSTING, BETTINA BASLER, REINHARD JESCHKE, and HELGE HEBESTREIT

Kinderklinik und Institut für Klinische Biochemie und Pathobiochemie, Universität Würzburg, Würzburg, Germany

The aim of this study was to determine the effects of a single exercise bout on luminal Cl and Na⁺ conductance in the respiratory epithelium of patients with cystic fibrosis (CF). In nine patients with CF and nine healthy control subjects, the transepithelial electrical potential difference (PD) of the nasal respiratory epithelium was recorded, first at rest and then during moderate-intensity exercise. Under both conditions, PD was first measured while superfusing the epithelium with isotonic saline. Then, the effects of amiloride and amiloride plus low chloride plus isoproterenol were determined. Exercise resulted in a significant lower PD compared with rest in patients with CF (6.6 ± 16.6 mV versus 33.6 ± 10.0 mV, p < 0.0001) and control subjects (0.1 ± 8.7 mV versus 7.1 ± 5.1 mV, p < 0.01). The effects of amiloride on PD were reduced during exercise compared with rest in patients with CF (+15.8 ± 9.5 mV versus +26.1 ± 11.0 mV, p < 0.01) and control subjects (+5.8 ± 4.8 mV versus +10.0 ± 3.1 mV, p < 0.01). There was no effect of exercise on chloride conductance in patients with CF and control subjects. We conclude that moderate-intensity exercise partially blocks the amiloride-sensitive sodium conductance in the respiratory epithelium. The inhibition of luminal sodium conductance could increase water content of the mucus in the CF lung during exercise and may, in part, explain the beneficial effects of exercise in patients with CF.

Keywords: CF; nasal potential difference; cycle ergometry; CFTR; amiloride sensitive sodium channel

This article has been cited by other articles:

				Y. Yaakov, E. Kerem, Y. Yahav, J. Rivlin, H. Blau, L. Bentur, M. Aviram, E. Picard, T. Bdolah-Abram, and M. Wilschanski Reproducibility of Nasal Potential Difference Measurements in Cystic Fibrosis Chest, October 1, 2007; 132(4): 1219 - 1226. [Abstract] [Full Text] [PDF]

				R. Tarran, B. Button, M. Picher, A. M. Paradiso, C. M. Ribeiro, E. R. Lazarowski, L. Zhang, P. L. Collins, R. J. Pickles, J. J. Fredberg, et al. Normal and Cystic Fibrosis Airway Surface Liquid Homeostasis: THE EFFECTS OF PHASIC SHEAR STRESS AND VIRAL INFECTIONS J. Biol. Chem., October 21, 2005; 280(42): 35751 - 35759. [Abstract] [Full Text] [PDF]

				M E Dodd and S A Prasad Physiotherapy management of cystic fibrosis Chronic Respiratory Disease, July 1, 2005; 2(3): 139 - 149. [Abstract] [PDF]

				M. G. Davies, D. M. Geddes, and E. W. F. W. Alton The Effect of Varying Tonicity on Nasal Epithelial Ion Transport in Cystic Fibrosis Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 760 - 763. [Abstract] [Full Text] [PDF]

				H. Mairbaurl, J. Weymann, A. Mohrlein, E. R. Swenson, M. Maggiorini, J. S. R. Gibbs, and P. Bartsch Nasal Epithelium Potential Difference at High Altitude (4,559 m): Evidence for Secretion Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 862 - 867. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 619 - 630. [Full Text] [PDF]